These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16800389)
21. [Vaccination with human "papillomavirus-like particles"]. Funk JO Hautarzt; 2003 Feb; 54(2):192-3. PubMed ID: 12590315 [No Abstract] [Full Text] [Related]
22. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers. Ling M; Kanayama M; Roden R; Wu TC J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133 [TBL] [Abstract][Full Text] [Related]
23. Immune intervention in HPV infections: current progress and future developments. Stanley M Expert Rev Vaccines; 2003 Oct; 2(5):615-7. PubMed ID: 14711323 [No Abstract] [Full Text] [Related]
24. [Vaccination against human papillomavirus for the prevention of cervical cancer]. Quint WG; ter Harmsel WA; van Doorn LJ Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585 [TBL] [Abstract][Full Text] [Related]
25. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer]. Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657 [TBL] [Abstract][Full Text] [Related]
26. Developments in L2-based human papillomavirus (HPV) vaccines. Schellenbacher C; Roden RBS; Kirnbauer R Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616 [TBL] [Abstract][Full Text] [Related]
27. Is the public enough aware to accept a vaccination program against human papillomavirus? Tjalma WA; Van Damme P Vaccine; 2005 May; 23(25):3231. PubMed ID: 15837225 [No Abstract] [Full Text] [Related]
28. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases. Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817 [TBL] [Abstract][Full Text] [Related]
29. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination. Lehtinen M; Apter D Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204 [TBL] [Abstract][Full Text] [Related]
30. Preventive vaccines for cervical cancer. Wheeler CM Salud Publica Mex; 1997; 39(4):283-7. PubMed ID: 9337561 [TBL] [Abstract][Full Text] [Related]
31. Towards vaccines against human papillomavirus type-16 genital infections. Cason J; Khan SA; Best JM Vaccine; 1993; 11(6):603-11. PubMed ID: 8391738 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of preventive human papillomavirus vaccination. Lehtinen M; Paavonen J Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583 [TBL] [Abstract][Full Text] [Related]
33. Can male vaccination reduce the burden of human papillomavirus-related disease in the United States? Low GM; Attiga YS; Garg G; Schlegal R; Gallicano GI Viral Immunol; 2012 Jun; 25(3):174-86. PubMed ID: 22691099 [TBL] [Abstract][Full Text] [Related]
34. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges. Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574 [TBL] [Abstract][Full Text] [Related]
35. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Adams M; Jasani B; Fiander A Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517 [TBL] [Abstract][Full Text] [Related]
36. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer. Ault K; Reisinger K Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242 [TBL] [Abstract][Full Text] [Related]
37. The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Yang A; Farmer E; Lin J; Wu TC; Hung CF Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207 [TBL] [Abstract][Full Text] [Related]